Lv512
968 积分 2024-10-17 加入
Metabolic dysfunction-associated steatotic liver disease and risk of cardiovascular disease
8天前
已完结
Non-invasive tests accurately stratify patients with NAFLD based on their risk of liver-related events
8天前
已完结
VCTE-Prognosis Study Group Long-term liver-related outcomes and liver stiffness progression of statin usage in steatotic liver disease
8天前
已完结
VCTE-Prognosis Study Group Vibration-controlled transient elastography scores to predict liver-related events in steatotic liver disease
8天前
已完结
Comparing serial and current liver stiffness measurements to predict decompensation in compensated advanced chronic liver disease patients
8天前
已完结
Longitudinal Changes in Fibrosis Markers: Monitoring Stiffness/Fibrosis Progression and Prognostic Outcomes in MASLD
8天前
已完结
Long-term liver-related outcomes and liver stiffness progression of statin usage in steatotic liver disease
8天前
已完结
Empagliflozin versus sitagliptin for ameliorating intrahepatic lipid content and tissue‐specific insulin sensitivity in patients with early‐stage type 2 diabetes with non‐alcoholic fatty liver disease: A prospective randomized study
20天前
已完结
Phase 3 Trial of Semaglutide in Metabolic Dysfunction–Associated Steatohepatitis
20天前
已完结
Use of liver stiffness measurement for hepatocellular carcinoma risk stratification in metabolic dysfunction associated steatotic liver disease
23天前
已完结
皖公网安备34019202002308
